We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.64%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.26B
AUM Growth
-$618M
(-11%)
Cap. Flow
-$615M
Cap. Flow
% of AUM
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
928
New
151
Increased
197
Reduced
368
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.8M |
| 2 |
UnitedHealth
UNH
|
+$42.1M |
| 3 |
Verizon
VZ
|
+$32.3M |
| 4 |
Comcast
CMCSA
|
+$29.1M |
| 5 |
Citigroup
C
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$70.8M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$36.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$31.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Healthcare | 17.4% |
| 3 | Technology | 16.88% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Unum
UNM
$13.8B
| $4.05M | 0.08% |
113,265
+12,990
| +13% | +$454K |
|
252
Cirrus Logic
CRUS
$6.74B
| $3.97M | 0.08% |
+116,770
| New | +$4.12M |
|
253
Itron
ITRI
$3.73B
| $3.96M | 0.08% |
115,022
-83,605
| -42% | -$3.04M |
|
|
BERY
254
DELISTED
Berry Global Group, Inc.
BERY
| $3.96M | 0.08% |
133,065
-38,570
| -22% | -$1.21M |
|
255
Xcel Energy
XEL
$51B
| $3.95M | 0.08% |
122,790
+37,920
| +45% | +$1.28M |
|
|
SIGM
256
DELISTED
Sigma Designs Inc
SIGM
| $3.92M | 0.07% |
328,187
+55,900
| +21% | +$513K |
|
|
BLOX
257
DELISTED
Infoblox Inc
BLOX
| $3.9M | 0.07% |
148,783
-33,200
| -18% | -$838K |
|
258
Zoetis
ZTS
$31.6B
| $3.86M | 0.07% |
80,080
-110
| -0.1% | -$5.25K |
|
259
Arrow Electronics
ARW
$10.9B
| $3.85M | 0.07% |
+69,058
| New | +$4.2M |
|
260
Allegiant Air
ALGT
$2.64B
| $3.83M | 0.07% |
21,537
+1,710
| +9% | +$284K |
|
|
CBM
261
DELISTED
Cambrex Corporation
CBM
| $3.76M | 0.07% |
85,659
-5,430
| -6% | -$225K |
|
262
Lumen
LUMN
$6.53B
| $3.72M | 0.07% |
126,548
-3,040
| -2% | -$104K |
|
263
Raymond James Financial
RJF
$32.5B
| $3.71M | 0.07% |
93,498
-125,562
| -57% | -$4.88M |
|
264
Delek US
DK
$3.87B
| $3.68M | 0.07% |
99,980
-105,575
| -51% | -$3.97M |
|
265
AptarGroup
ATR
$8.45B
| $3.67M | 0.07% |
57,565
-4,900
| -8% | -$313K |
|
|
IDTI
266
DELISTED
Integrated Device Technology I
IDTI
| $3.65M | 0.07% |
168,400
+17,900
| +12% | +$386K |
|
267
Targa Resources
TRGP
$60.4B
| $3.65M | 0.07% |
40,851
-15,302
| -27% | -$1.49M |
|
268
Lear
LEA
$7.19B
| $3.61M | 0.07% |
+32,154
| New | +$3.69M |
|
269
Harmonic Inc
HLIT
$1.21B
| $3.61M | 0.07% |
528,195
-62,111
| -11% | -$442K |
|
|
CSGS
270
DELISTED
CSG Systems International
CSGS
| $3.59M | 0.07% |
113,497
-6,500
| -5% | -$200K |
|
|
CSH
271
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $3.55M | 0.07% |
+135,657
| New | +$3.6M |
|
272
Travel + Leisure Co
TNL
$4.54B
| $3.53M | 0.07% |
95,467
+2,215
| +2% | +$86.8K |
|
|
VAL
273
DELISTED
Valspar
VAL
| $3.53M | 0.07% |
43,140
-51,113
| -54% | -$4.28M |
|
274
MaxLinear
MXL
$6.49B
| $3.51M | 0.07% |
290,445
+173,049
| +147% | +$1.74M |
|
275
Emergent Biosolutions
EBS
$375M
| $3.5M | 0.07% |
106,073
-2,470
| -2% | -$76.6K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2015 Portfolio in Review
As of Q2 2015, Jacobs Levy Equity Management held 928 positions worth $5.26B, down 11% from $5.88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jacobs Levy Equity Management withdrew a net $615M in Q2 2015, closing 132 positions and reducing 368 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $31.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jacobs Levy Equity Management opened a new position in UnitedHealth worth $43.4M.
- Jacobs Levy Equity Management's largest Q2 2015 buy was UnitedHealth: 355,991 shares worth $43.4M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q2 2015, an estimated $43.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2015 reduction was Microsoft, cutting an estimated $70.8M.
- Jacobs Levy Equity Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $31.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.26B portfolio in Q2 2015.
- Jacobs Levy Equity Management opened 151 new positions and closed 132 in Q2 2015.
- Jacobs Levy Equity Management's portfolio value fell 11% quarter-over-quarter to $5.26B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.